Brief International Cognitive Assessment for MS (BICAMS): international standards for validation

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Benedict, Ralph H B ^a   Amato, Maria P ^a   Boringa, Jan ^a   Brochet, Bruno ^a   Foley, Fred ^a   Fredrikson, Stan ^a   Hamalainen, Paivi ^a   Hartung, Hans ^a   Krupp, Lauren ^a   Penner, Iris ^a   Reder, Anthony T ^a   Langdon, Dawn ^a  

^a Maskun Neurologinen Kuntoutuskeskus   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS; COGNITION; CONSENSUS; DIAGNOSTIC ACCURACY; HUMAN; LEARNING; MULTIPLE SCLEROSIS; PSYCHOLOGIC TEST; PSYCHOMETRY; RELIABILITY; SPATIAL MEMORY; STANDARDIZATION; VALIDITY; VISUAL MEMORY;

ADULT; COGNITION; COGNITION DISORDERS; HUMANS; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84866682272     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-55     Document Type: Article

References (58)

1. Hauser SL, Oksenberg JR, Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006, 52:61-76. 10.1016/j.neuron.2006.09.011, 17015227.
2. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 2008, 31:247-269. 10.1146/annurev.neuro.30.051606.094313, 18558855.
3. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991, 41:685-691. 10.1212/WNL.41.5.685, 2027484.
4. Benedict RHB, Cookfair D, Gavett R, et al. Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). J Int Neuropsychol Soc 2006, 12:549-558.
5. Patti F, Amato M, Trojano M, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler 2009, 15:779-788. 10.1177/1352458509105544, 19542262.
6. Glanz BI, Holland CM, Gauthier SA, et al. Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. Mult Scler 2007, 13:1004-1010. 10.1177/1352458507077943, 17623735.
7. Benedict RHB. Integrating cognitive function screening and assessment into the routine care of multiple sclerosis patients 2005, CNS Spectrums, , in press.
8. Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2011,
9. Wechsler D. Wechsler Adult Intelligence Scale 2008, Pearson, New York, 4.
10. Lezak M. Neuropsychological Assessment 1995, Oxford University Press, New York, 2.
11. Langdon DW, Amato MP, Boringa J, et al. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Multiple Sclerosis Journal in press.
12. Rao SM. A Manual for the Brief, Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis: National Multiple Sclerosis Society 1991, , .
13. Smith A. Symbol digit modalities test: Manual 1982, Western Psychological Services, Los Angeles.
14. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test Manual: Second Edition, Adult Version 2000, Psychological Corporation, San Antonio, TX.
15. Benedict RHB. Brief Visuospatial Memory Test - Revised: Professional Manual 1997, Psychological Assessment Resources, Inc., Odessa, Floriday.
16. Benedict RHB, Schretlen DS, Groninger L, Dobraski M. Revision of the brief Vislospatial Meuoz Test: studies of normal performance, reliability and validity. Psychological Assesment 1996, 8:145-153.
17. Stegen S, Stepanov I, Cookfair D, et al. Validity of the California Verbal Learning Test-II in Multiple Sclerosis. Clin Neuropsychol 2009, 24:189-202.
18. Benedict R. Brief Visuospatial Memory Test-Revised: Professional manual 1997, Psychological Assessment Resources, Odessa, Florida.
19. Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, Benedict RH. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult Scler 2009, 15:1077-1084. 10.1177/1352458509106615, 19556311.
20. Buchanan RW, Davis M, Goff D, et al. A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia. Schizophr Bull 2005, 31:5-19. 10.1093/schbul/sbi020, 15888422.
21. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to Neuropsychological Assessment 1994, Oxford University Press, New York, 2.
22. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary 1998, Oxford University Press, New York, 2.
23. Anastasi A. Psychological Testing 1988, Macmillan Publishing Company, , 6.
24. Benedict RHB, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of ms patients: a consensus approach. Clin Neuropsychol 2002, 16:381-397. 10.1076/clin.16.3.381.13859, 12607150.
25. Amato MP, Zipoli V, Portaccio E. Mulitple-sclerosis related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 2006, 245:41-46. 10.1016/j.jns.2005.08.019, 16643953.
26. Camp SJ, Thompson AJ, Langdon DW. A new test of memory for multiple sclerosis I: format development and stimuli design. Mult Scler 2001, 7:255-262.
27. Benedict RHB, Brandt J. Hopkins Verbal Learning Test Revised and Brief Visuospatial Memory Test Revised: Professional Manual Supplement 2007, Psychological Assessment Resources, Inc, Odessa, Fl.
28. Parmenter BA, Testa SM, Schretlen DJ, Weinstock-Guttman B, Benedict RHB. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2010, 16:6-16. 10.1017/S1355617709990750, 19796441.
29. Horsfield MA, Rovaris M, Rocca MA, et al. Whole-brain atrophy in multiple sclerosis measured by two segmentation processes from various MRI sequences. J Neurol Sci 2003, 216:169-177. 10.1016/j.jns.2003.07.003, 14607319.
30. Cohen J, Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences 1983, Lawrence Erlbaum, Hillsdale, NJ, 2.
31. Benedict RHB. Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis. J Int Neuropsychol Soc 2005, 11:727-736.
32. King MT. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 2011, 11:171-184. 10.1586/erp.11.9, 21476819.
33. Langdon DW, Thompson AJ. Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. Mult Scler 1999, 5:94-100.
34. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis: Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 1995, 52:168-172. 10.1001/archneur.1995.00540260072019, 7848126.
35. Jean VM, Paul RH, Beatty WW. Psychological and neuropsychological predictors of coping patterns by patients with multiple sclerosis. J Clin Psychol 1999, 55:21-26. 10.1002/(SICI)1097-4679(199901)55:1<21::AID-JCLP2>3.0.CO;2-B, 10100828.
36. Schultheis MT, Garay E, Millis SR, DeLuca J. Motor vehicle crashes and violations among drivers with multiple sclerosis. Arch Phys Med Rehabil 2002, 83:1175-1178. 10.1053/apmr.2002.34279, 12161844.
37. Goverover Y, Kalmar J, Gaudino-Goering E, et al. The relation between subjective and objective measures of everyday life activities in persons with multiple sclerosis. Arch Phys Med Rehabil 2005, 86:2303-2308. 10.1016/j.apmr.2005.05.016, 16344027.
38. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology 1999, 53:1098-1103. 10.1212/WNL.53.5.1098, 10496273.
39. Goverover Y, Genova HM, Hillary FG, DeLuca J. The relationship between neuropsychological measures and the Timed Instrumental Activities of Daily Living task in multiple sclerosis. Mult Scler 2007, 13:636-644. 10.1177/1352458506072984, 17548444.
40. Schultheis MT, Weisser V, Ang J, et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch Phys Med Rehabil 2010, 91:465-473. 10.1016/j.apmr.2009.09.026, 20298841.
41. Beatty WW, Goretti B, Siracusa G, Zipoli V, Portaccio E, Amato MP. Changes in neuropsychological test performance over the workday in multiple sclerosis. Clin Neuropsychol 2003, 17:551-560. 10.1076/clin.17.4.551.27942, 15168919.
42. Goretti B, Portaccio E, Zipoli V, Razzolini L, Amato MP. Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. Neurol Sci 2010, 31:S227-S230.
43. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unveragt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991, 41:692-696. 10.1212/WNL.41.5.692, 1823781.
44. LaRocca NG, Kalb RC, Gregg K. A program to facilitate retention of employment among persons with multiple sclerosis. Work 1996, 7:37-46.
45. Benedict RHB, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005, 231:29-34. 10.1016/j.jns.2004.12.009, 15792817.
46. Benedict RHB, Zivadinov R. Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 2006, 245:67-72. 10.1016/j.jns.2005.05.020, 16626751.
47. Parmenter BA, Zivadinov R, Kerenyi L, et al. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) sorting tests in multiple sclerosis. J Clin Exp Neuropsychol 2007, 29:215-223. 10.1080/13803390600672163, 17365256.
48. Morrow SA, Drake AS, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RHB. Predicting loss of employment over three years in multiple sclerosis: Clinically meaningful cognitive decline. Clin Neuropsychol in press.
49. Benedict RHB, Zgaljardic DJ. Practice effects during repeated administrations of memory tests with and without alternate forms. J Clin Exp Neuropsychol 1998, 20:339-352. 10.1076/jcen.20.3.339.822, 9845161.
50. Boringa JB, Lazeron RH, Reuling IE, et al. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001, 7:263-267.
51. Benedict RH, Smerbeck A, Parikh R, Rodgers J, Cadavid D, Erlanger D. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials. Mult Scler 2012,
52. Benedict RHB, Groninger L. Preliminary standardization and validation of a new visuospatial memory test with six alternate forms. Clin Neuropsychol 1995, 9:11-16.
53. Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess 1996, 8:145-153.
54. Green MF, Nuechterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res 2004, 72:1-3. 10.1016/j.schres.2004.09.006, 15531401.
55. Rey A. L'Examen Clinique en Psychologie 1964, Press Universitaire de France, Paris.
56. Benedict RHB, Schretlen D, Brandt J, Groninger L. Revision of the Hopkins verbal learning test: reliability and normative data. Clin Neuropsychol 1998, 12:43-55.
57. Shapiro AM, Benedict RHB, Schretlen D, Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test - Revised. Clin Neuropsychol 1999, 13:348-358. 10.1076/clin.13.3.348.1749, 10726605.
58. Trojano M. Multiple sclerosis: the evolving diagnostic criteria for multiple sclerosis. Nat Rev Neurol 2011, 7:251-252. 10.1038/nrneurol.2011.55, 21537354.